| Dr Andrea B Schneebaum, MD | |
|
6 Tsienneto Rd, Suite 300, Derry, NH 03038-1584 | |
| (603) 216-0400 | |
| (603) 216-3800 |
| Full Name | Dr Andrea B Schneebaum |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 43 Years |
| Location | 6 Tsienneto Rd, Derry, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205930872 | NPI | - | NPPES |
| 30201363 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 11106 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern New Hampshire Internal Medicine Associates Pc | 9133111990 | 12 |
News Archive
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
Brain tumors called ependymomas that occur in different parts of the central nervous system appear to arise from subpopulations of stem cells called radial glia cells (RGCs), according to investigators at St. Jude Children's Research Hospital. The discovery explains why some identical-looking ependymomas are actually distinctly different diseases, the researchers said.
Tyco International Ltd. announced today that it has reached an agreement to acquire Visonic Ltd., a global developer and manufacturer of electronic security systems and components, for approximately $100 million in cash. The acquisition will strengthen the wireless product and technology portfolio and market presence of the Tyco Security Products business in the intrusion security market.
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof.
› Verified 1 days ago
| Entity Name | Southern New Hampshire Internal Medicine Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316026677 PECOS PAC ID: 9133111990 Enrollment ID: O20040401000153 |
News Archive
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
Brain tumors called ependymomas that occur in different parts of the central nervous system appear to arise from subpopulations of stem cells called radial glia cells (RGCs), according to investigators at St. Jude Children's Research Hospital. The discovery explains why some identical-looking ependymomas are actually distinctly different diseases, the researchers said.
Tyco International Ltd. announced today that it has reached an agreement to acquire Visonic Ltd., a global developer and manufacturer of electronic security systems and components, for approximately $100 million in cash. The acquisition will strengthen the wireless product and technology portfolio and market presence of the Tyco Security Products business in the intrusion security market.
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea B Schneebaum, MD 6 Tsienneto Rd, Suite 300, Derry, NH 03038-1584 Ph: (603) 216-0400 | Dr Andrea B Schneebaum, MD 6 Tsienneto Rd, Suite 300, Derry, NH 03038-1584 Ph: (603) 216-0400 |
News Archive
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
Brain tumors called ependymomas that occur in different parts of the central nervous system appear to arise from subpopulations of stem cells called radial glia cells (RGCs), according to investigators at St. Jude Children's Research Hospital. The discovery explains why some identical-looking ependymomas are actually distinctly different diseases, the researchers said.
Tyco International Ltd. announced today that it has reached an agreement to acquire Visonic Ltd., a global developer and manufacturer of electronic security systems and components, for approximately $100 million in cash. The acquisition will strengthen the wireless product and technology portfolio and market presence of the Tyco Security Products business in the intrusion security market.
There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof.
› Verified 1 days ago
Dr. Zachary S Spigelman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 204, Derry, NH 03038 Phone: 603-421-2156 Fax: 603-421-2307 | |
Dr. Paul Michael Macdonald, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 | |
Steven Taylor, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Road, Suite 301, Derry, NH 03038 Phone: 603-432-8802 Fax: 603-432-7430 | |
Dr. Knut Roalsvig, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 301, Derry, NH 03038 Phone: 603-432-8802 Fax: 603-432-7430 | |
Dr. Laura Jean Fox, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 | |
Dr. Edmund S Schiavoni Jr., MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Road, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 |